As the year draws to a close, early-stage venture capital investment continues to slow, according to data from Crunchbase. However, BoxGroup is a VC firm that keeps the investment train rolling.
TechCrunch has learned exclusively that the New York and San Francisco-based firm has quietly closed on $425 million in capital commitments to two new funds: BoxGroup Six, a pre-seed and seed-stage fund, and BoxGroup Picks, the third opportunity chapter. Each fund is $212.5 million, said partner David Tisch.
The 13-year-old company has made investments in companies including Ramp, Warp, Hex, Solugen, Vial, Arcadia, Nourish, Coast, Turquoise Health and Backbone.
Tisch describes BoxGroup as a generalist firm that invests in five “buckets”: consumer businesses, healthcare, financials, biotech and climate. The four partners have worked together for the better part of a decade and recently brought on two new partners to make it an eight-person firm.
The new funds come two years after BoxGroup raised $255 million for its fifth seed-stage and second-chance fund. The sixth early-stage fund is nearly double the size of the fifth, Tisch notes.
“For our early-stage fund, we’ve grown, which in this environment is remarkable,” Tisch said. “Actually, it’s a pretty significant growth of the early stage fund. In doing so, we’ve been able to bring in a handful of new collaborators that we’re really excited about, including some big institutional LPs joining the fold this time around.”
BoxGroup invests in the early stages — pre-seed, seed and Series A, often leading to a pre-seed round. Similar to previous funds, Tisch expects to infuse capital from the new funds into 40 to 50 new startups, writing check sizes between $500,000 and $1 million.
At the core of BoxGroup’s investments are first-time founders. However, Tisch recently said the company has been in talks with second and third-party founders, including many it had not previously backed.
Tisch says that one of the reasons for the slowdown in investment this year was that rate of company creation, saying it was “dramatically lower than at any point in my 14-year career, below 75%.”
“You can see some of that in the macro numbers around business and financing, but we were really seeing it and feeling it,” Tisch said. “If you look back at the timing of our last hike until now, when we hiked in 2021, the market was crazy. In the last six months, we have seen a return to what I would call normalcy. It looks more like the 2018 and 2019 market.”
He also notes that “it’s an exciting time to be an early-stage investor,” for a few reasons. First, AI is rekindling investments. Second, founders know the fundraising market isn’t easy, so they start companies “with more intent and thought around the opportunities that are out there.”
